MetLife Investment Management’s AFC Gamma AFCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,072
Closed -$83.9K 2782
2024
Q4
$83.9K Hold
10,072
﹤0.01% 2682
2024
Q3
$103K Sell
10,072
-4,643
-32% -$44.9K ﹤0.01% 2617
2024
Q2
$123K Buy
14,715
+1,578
+12% +$13K ﹤0.01% 2497
2024
Q1
$111K Hold
13,137
﹤0.01% 2481
2023
Q4
$108K Hold
13,137
﹤0.01% 2575
2023
Q3
$106K Hold
13,137
﹤0.01% 2554
2023
Q2
$112K Hold
13,137
﹤0.01% 2610
2023
Q1
$109K Hold
13,137
﹤0.01% 2509
2022
Q4
$141K Hold
13,137
﹤0.01% 2440
2022
Q3
$138K Hold
13,137
﹤0.01% 2514
2022
Q2
$138K Hold
13,137
﹤0.01% 2547
2022
Q1
$172K Buy
13,137
+4,684
+55% +$63.3K ﹤0.01% 2450
2021
Q4
$132K Buy
+8,453
New +$132K ﹤0.01% 2303

Other funds holding AFCG

MetLife Investment Management's AFCG Position: Q1 2025 in Review

MetLife Investment Management sold out of AFC Gamma (AFCG) in Q1 2025, closing a stake of 10,072 shares — an estimated $83.9K sold.

MetLife Investment Management first reported a position in AFCG in Q4 2021 and held it in 13 quarters. The position peaked at $172K in Q1 2022. 84 funds tracked by Wall St. Rank hold AFCG as of Q1 2025.

  • MetLife Investment Management reported no remaining AFC Gamma position as of Q1 2025 after selling out during the quarter.
  • MetLife Investment Management sold 10,072 AFC Gamma shares in Q1 2025, an estimated $83.9K.
  • MetLife Investment Management first reported a position in AFC Gamma in Q4 2021 and held it in 13 quarters.
  • MetLife Investment Management's AFC Gamma position peaked at $172K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held AFC Gamma as of Q1 2025.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.